This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Jul;163(1):338-339.

doi: 10.1053/j.gastro.2022.03.008. Epub 2022 Mar 12.

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?

Yuki Hayashi¹, Hiroshi Nakase¹, Tadakazu Hisamatsu²; J-COSMOS group

Affiliations

Affiliations

¹ Department of Gastroenterology and Hepatology, Sapporo Medical University of Medicine, Sapporo, Japan.
² Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.

PMID: 35288110
PMCID: PMC8916839
DOI: 10.1053/j.gastro.2022.03.008

Comment

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?

Yuki Hayashi et al. Gastroenterology. 2022 Jul.

. 2022 Jul;163(1):338-339.

doi: 10.1053/j.gastro.2022.03.008. Epub 2022 Mar 12.

Authors

Yuki Hayashi¹, Hiroshi Nakase¹, Tadakazu Hisamatsu²; J-COSMOS group

Affiliations

¹ Department of Gastroenterology and Hepatology, Sapporo Medical University of Medicine, Sapporo, Japan.
² Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.

PMID: 35288110
PMCID: PMC8916839
DOI: 10.1053/j.gastro.2022.03.008

No abstract available

PubMed Disclaimer

Comment on

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry.
Ungaro RC, Brenner EJ, Agrawal M, Zhang X, Kappelman MD, Colombel JF; Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) Research Group. Ungaro RC, et al. Gastroenterology. 2022 Jan;162(1):316-319.e5. doi: 10.1053/j.gastro.2021.09.011. Epub 2021 Sep 14. Gastroenterology. 2022. PMID: 34529987 Free PMC article. No abstract available.

References

1. Ungaro R.C., et al. Gastroenterology. 2022;162:316–319.e5. - PMC - PubMed
1. Allez M., et al. J Crohns Colitis. 2020;14:S774–S779. - PMC - PubMed
1. Magro F., et al. J Crohns Colitis. 2020;14:S798–S806. - PMC - PubMed
1. Nakase H., et al. Digestion. 2021;102:814–822. - PMC - PubMed
1. Nakase H, et al. J Gastroenterol 2922;57:174–184.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information